Meytel Segev

Title: Meytel Segev: Innovator in Cardiac Signal Detection

Introduction

Meytel Segev is a notable inventor based in Haifa, Israel. He has made significant contributions to the field of cardiac health through his innovative patent. His work focuses on improving the detection of arrhythmias, which can have serious implications for patient care.

Latest Patents

Meytel Segev holds a patent for the "Detection of fractionated signals in stable arrhythmias." This patent describes a method that includes receiving a cardiac signal sensed by an electrode at a tissue location inside the heart. The method identifies fractionations in the cardiac signal and compares these fractionations between the first and second cardiac cycles. Based on this comparison, the likelihood that the tissue location is causing a stable arrhythmia is estimated. This information is then indicated to a user, highlighting the tissue location that may be responsible for the arrhythmia.

Career Highlights

Meytel Segev is currently employed at Biosense Webster (Israel) Ltd., where he continues to develop innovative solutions in the medical technology sector. His work is crucial in enhancing the accuracy of cardiac diagnostics, ultimately improving patient outcomes.

Collaborations

Meytel collaborates with talented professionals in his field, including Eliyahu Ravuna and Leonid Zaides. Their combined expertise contributes to the advancement of cardiac signal detection technologies.

Conclusion

Meytel Segev's contributions to cardiac health through his innovative patent demonstrate his commitment to improving medical technology. His work has the potential to significantly impact patient care in the field of cardiology.